Delivery Order SPE2DR25D2206-SPE2DR26F9CA2
- Not listed
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,205.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical transaction under AmerisourceBergen's existing contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,269.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,431.61 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to conclude by October 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the Department of Defense...
- The Defense Logistics Agency awarded a $16,313.49 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9CA2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,492.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the contractor's pharmaceutical supply services to the federal government. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs, including the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of competitively awarded federal contracts demonstrating its capability to fulfill diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 11/17/25 |